GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (OTCPK:VIVXF) » Definitions » Buyback Yield %

Avivagen (Avivagen) Buyback Yield % : 672.44 (As of May. 05, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Avivagen Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Avivagen's current buyback yield was 672.44%.


Avivagen Buyback Yield % Historical Data

The historical data trend for Avivagen's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen Buyback Yield % Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.88 -7.31 -15.10 -35.28 -37.34

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.62 97.71 - -5.45 -

Competitive Comparison of Avivagen's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Avivagen's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avivagen's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avivagen's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Avivagen's Buyback Yield % falls into.



Avivagen Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Avivagen's Buyback Yield for the fiscal year that ended in Oct. 2022 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 2.943) / 7.88083354
=-37.34%

Avivagen's annualized Buyback Yield for the quarter that ended in Jul. 2023 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 / 0.86241117
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Jul. 2023) data.


Avivagen Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Avivagen's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Avivagen (Avivagen) Business Description

Traded in Other Exchanges
Address
100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.

Avivagen (Avivagen) Headlines

From GuruFocus

Avivagen Announces OxC-beta™ Purchase Order with New Customer

By Marketwired Marketwired 04-25-2018

Avivagen Announces Distribution in China for Vivamune

By Marketwired Marketwired 06-01-2018

Avivagen to Pursue Regulatory Approval in Mexico

By Marketwired Marketwired 05-25-2018

Avivagen to Exhibit Vivamune at SuperZoo

By Marketwired Marketwired 06-22-2018

Avivagen Announces CEO Letter to Shareholders

By Marketwired Marketwired 01-17-2019

AVIVAGEN to Present at The LD 500 Virtual Conference

By ACCESSWIRE ACCESSWIRE 08-31-2020